US FDA appoints Elizabeth Dickinson as permanent chief counsel
This article was originally published in SRA
Executive Summary
Elizabeth Dickinson, the US Food and Drug Administration's acting chief counsel since August 2011, will take on this role on a permanent basis as of 12 March1.